Week 4 - RBC Disorders Flashcards

1
Q

Define anaemia.

A

• Decreased red cell mass affecting tissue oxygenation.
• Diagnosed using haematocrit or Hb levels (characterised by low Hb* or low HCT).
*Hb may be high but not functioning properly → clinical features of anaemia except pallor e.g. smokers (due to CO poisoning - Hb irreversibly bound to CO).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 4 main causes of anaemia?

A
  • Failure of erythrocyte production.
  • Loss of erythrocytes.
  • Abnormality of erythrocytes.
  • Destruction of erythrocytes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Outline the classification of anaemia.

A

Decreased production - deficiency anaemia
• Nutrient deficiency:
- Iron deficiency (IDA)/Megaloblastic (MBA).
• Haemopoietic cell defect:
- Anaemia of chronic disorders (ACD).
- Aplastic anaemia (AA).
- Dysplastic anaemia. Myelodysplastic Syndromes.

Increased loss/destruction - haemolytic anaemia
• Blood loss anaemia - acute/chronic - bleeding.
• Haemolytic anaemia - congenital/acquired.
▫ Acquired/external injury:
- Immune AIHA (warm/cold), mechanical, drugs, infections (e.g. clostridia, septicaemia) and parasites (e.g. malaria).
▫ Congenital/internal RBC defect:
- Defective membrane (spherocytic anaemia).
- Defective haemoglobin (qualitative - abnormal function: sickle cell anaemia. Quantitative - abnormal amount: Thalassemia α,β,δ).
- Defective enzyme (G6PD deficiency).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Outline haemopoiesis.

A
  • Formation of blood cells.
  • Starts from a common precursor cell.
  • In foetus, occurs in yolk sack, liver & spleen.
  • In children, occurs in distal long bones & axial skeleton.
  • In adults, this occurs in the axial skeleton.
  • In disease, can revert to use of early organs.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe RBC development.

A
  • Stem cell → Committed cell → Developmental pathway (ribosome synthesis, Hb accumulation, ejection of nucleus).
  • Blast early → Intermediate → Late → Reticulocyte → RBC.
  • RBCs produced through maturation of erythroblasts gradually losing the nucleus and dividing multiple times finally giving rise to RBC.
  • Cells dividing at each step, nucleus gradually becoming smaller.
  • Gradual accumulation of Hb replacing all the other constituents of the cell.
  • When there is no further division → nucleus ejected from cell.
  • Mature RBC - Hb and enzymes, no cellular organelles.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are 2 important constituents for RBC formation?

A
  1. Hb - iron required for Hb production in cytoplasm. Deficiency of iron → IDA.
  2. DNA - B12 and folate required for DNA synthesis. Without DNA, cells cannot fully mature and divide → MBA.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Outline the normal values for RBC indices.

A
  • Hb - amount of Hb per RBC - 15 +/- 2.5 (grams/dl).
  • RBC count - total no. of RBCs - 4.8 +/- 1 x 10^12/L.
  • HCT/PCV - packed cell volume - proportion of blood occupied by RBCs - 0.47 +/- 0.07 (lit/lit (%)).
  • MCV - average volume of RBCs - 80-100fL.
  • MCH - average mass of Hb per RBC - 30 +/- 2.5 (picograms/L).
  • MCHC - average concentration of Hb per RBC - 31.6-34.9 (grams/100mL).
  • RDW - variation in RBC size/volume - 11.5-14.5%.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Outline the aetiology of iron deficiency anaemia.

A
  • Is the most common cause of anaemia.
  • Bleeding - commonest e.g. blood loss from GIT (bowel cancer, PUD, gastritis, NSAID/aspirin use, hookworm, IBD, diverticulitis, polyps), menstrual loss, gynaecological, multiple pregnancies, parasites.
  • Nutrition - dietary deficiency. Good sources of iron are meat, fish, cabbage, broccoli, peas, beans, iron-enriched cereals and bread.
  • Increased need - stores may be inadequate during periods of increased growth e.g. teenage years, pregnancy (growing foetus)/infancy.
  • Malabsorption - iron may be ingested but inadequately absorbed from GIT.
  • In developing countries, mainly due to blood loss from parasitic worm infestation + malnutrition.
  • In developed countries, mainly due to blood loss from malignancy.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the pathogenesis of iron deficiency anaemia.

A

Decreased iron → decreased Hb and excess cell division (normal DNA) leading to small RBCs (decreased MCV).

  1. Decreased iron stores.
  2. Decreased Hb synthesis (∴ only affect RBC).
  3. Delayed maturation of erythroblasts therefore remains in bone marrow for longer time (cytoplasmic).
  4. Decreased cytoplasm maturation → more divisions ∴ smaller cells (microcytes).
  5. Decreased Hb content (hypochromia).
  6. Anaemia.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Identify the clinical features of iron deficiency anaemia.

A
  • Tiredness
  • Weakness
  • Lethargy
  • Pallor
  • Glossitis
  • Chelitis
  • Stomatitis
  • Koilonychia
  • Dysphagia
  • Dyspnoea (on exertion)
  • Palpitations, chest pain → heart failure → pedal oedema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the morphology of iron deficiency anaemia.

A
  • Microcytic, hypochromic RBCs - excess cell division, low Hb.
  • Anisopoikilocytosis - varying supply, abnormal haemopoiesis.
  • Pencil cells - idiopathic.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Outline the investigations for iron deficiency anaemia.

A

FBC:
• Hb and MCV decreased - microcytic anaemia.
• MCH and MCHC decreased - hypochromic RBCs.
• RDW increased - anisocytosis (variation in size).
• Poikilocytosis - pencil and cigar poikilocytes characteristically seen (abnormally shaped RBC).
• Platelets increased - a thrombocytosis may be present.
• WCC normal - normal leucocytes.

Iron studies:
• Serum iron decreased.
• Transferrin increased.
• Total iron binding capacity increased.
• Transferrin saturation decreased.
• Serum ferritin decreased - best test to confirm IDA.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the management of iron deficiency anaemia.

A
  • Oral iron supplementation.
  • If the patient has angina, heart failure or evidence of cerebral hypoxia - should have transfusion.
  • Investigate cause (i.e. bleeding due to hookworm) and treat appropriately.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Outline megaloblastic anaemia.

A

• Second most common type of anaemia.
• Due to vitamin B12 (cobalamin) and/or folate deficiency.
- Vitamin B12 is synthesised only by microorganisms or come from animal food (i.e. meat, fish, dairy products).
- Folate is only found in uncooked plant food (yeast, spinach, other greens, mushrooms, nuts).
• The common feature of MBA is a defect in DNA synthesis that affects the rapidly dividing cells in the bone marrow.
• Affects all rapidly dividing cells (eg. epithelium).
• Can have pure folate or pure vitamin B12 deficiency but a combination is most common.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Outline the aetiology of megaloblastic anaemia.

A
  • Malnutrition - vegans/elderly due to impaired digestion and extraction of vitamin B12 from ingested food.
  • Autoimmune - pernicious anaemia - intrinsic factor antibodies causing atrophy of the gastric cells → failure of absorption of vitamin B12.
  • Gastrectomy (partial/total), ileal resection.
  • GI disorders - gastritis, chronic gastroenteritis, IBD.
  • Malabsorption syndromes - tropical sprue, blind loop syndrome.
  • Cancer/cancer therapy - cancers growing utilise all the available B12 and folate, patients may suffer deficiency. Many of the anti-cancer drugs are also inhibitors of folate (folate is necessary for cell division).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the pathogenesis of megaloblastic anaemia.

A

Both B12 and folate necessary for DNA synthesis. B12 and/or folate deficiency → decreased DNA → decreased cell division → decreased cells - all cells.

  1. Decreased vitamin B12 and/or folate.
  2. Decreased DNA synthesis.
  3. Delayed maturation of erythroblasts (nucleus).
  4. Increased cell size (macrocyte).
  5. Normal Hb content (normochromia), ↓ RBC number, ↓ WBC number (pancytopenia).
  6. Anaemia & Pancytopenia.
    - As it is due to a defect in DNA, it affects all cell lines.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Identify the clinical features of megaloblastic anaemia.

A

• May be asymptomatic (detected by increased MCV on routine blood count).
• Symptoms of anaemia.
• GIT symptoms - anorexia, weight loss, diarrhoea or constipation, glossitis, chelitis, mild jaundice (unconjugated - due to haemolysis).
• Skin pigmentation (pallor/jaundice).
• Bruising/mucosal haemorrhage and susceptibility to infections (particularly of the respiratory and urinary tract) - thrombocytopenia and leukopenia may occur.
• Lesions of nervous system due to vitamin B12 deficiency.
- Brain: lesions in the white matter → dementia.
- Peripheral nerves: degeneration of myelin sheaths.
- Spinal cord: lesions of corticospinal tracts and posterior columns.
• Mild fever in severely anaemic patients.
• Infertility in both men and women.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe the morphology of megaloblastic anaemia.

A
  • Oval macrocytic RBCs, pancytopenia - decreased cell division.
  • Anisopoikilocytosis - haemolysis.
  • Hypersegmented neutrophils - large cells/megaloblasts (in bone marrow).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Outline the investigations for megaloblastic anaemia.

A
FBC:
• Hb decreased, MCV increased.
• RBC count decreased.
• MCH high, MCHC normal - total Hb per RBC is high but the percentage of space occupied by Hb is the same (concentration is the same).
• WBCs, platelets decreased.
  • S-vitamin B12 level.
  • S-folate level, RBC folate.
  • Iron studies as a mixed deficiency may be present.

Antibodies:
• Intrinsic factor antibody
- Type I - blocking - Ab prevents the combination of IF and vitamin B12.
- Type II - binding - Ab prevents the attachment of IF to ileal mucosa.
• Parietal cell antibody.

Evidence for haemolysis:
• Urine - increased urobilinogen, haemosiderinuria.
• Blood - increased unconjugated bilirubin, decreased haptoglobin level, increased lactate dehydrogenase (LDH).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe the management of megaloblastic anaemia.

A

Vitamin B12 deficiency:
• Vitamin B12 injections - 1000μg weekly for a month, then monthly thereafter.
• Intranasal vitamin B12.
• Oral vitamin B12 - 1000μg daily for nutritional deficiency.

Folate deficiency:
• Folic acid 1-2mg orally daily.

• When treatment is commenced for vitamin B12 deficiency, or a mixed vitamin B12 and folate deficiency, the patient should receive a loading dose of Vitamin B12 prior to commencement of folate therapy, to prevent precipitation of subacute combined degeneration of the cord.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Outline pernicious anaemia.

A
  • Autoimmune atrophic gastritis in aged (vitamin B12 deficiency anaemia due to autoimmune atrophic gastritis).
  • IF and parietal cell antibody (type I, II, III).
  • Reduced tetra-hydrofolate (FH4).
  • Decreased DNA synthesis.
  • Severe lack of IF due to gastric atrophy. IF is required for absorption of vitamin B12 in the ileum.
  • Autoimmune gastritis - antibodies against intrinsic factor and parietal cell antibody which block vitamin B12 absorption giving rise to decreased tetra-hydrofolate (folic acid derivative) → results in decreased DNA synthesis.

• Clinical - MBA plus neurological deficits (spinal dorsal tract). Loss of proprioception.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Outline the aetiology of anaemia of chronic disease.

A
  • Impaired red blood cell production associated with chronic disease.
  • Is one of the most common types of anaemia.
  • Is frequently associated with other forms of anaemia.

• Aetiology: chronic infections, inflammatory conditions, malignancy and anaemia of renal disease* (anaemia seen in patients suffering from many other chronic disorders).
• Associated with a range of chronic inflammatory diseases:
- Chronic microbial infections (eg. osteomyelitis, bacterial endocarditis, lung abscess).
- Chronic immune disorders (eg. rheumatoid arthritis, regional enteritis).
- Neoplasms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Describe the pathogenesis of anaemia of chronic disease.

A
  • IFN, TNF, IL block iron transfer from macrophage store to RBC.
  • Decreased erythropoietin*
  • Any disorder → produces inflammation → inflammation produces inflammatory mediators → block iron transfer in the bone marrow from the macrophage to RBC.
  • Also enhances RBC phagocytosis by the macrophages. • Also inhibits EPO production.
  • All this together suppresses the production of RBCs and block the iron transfer. Functional iron deficiency.

• Occurs in inflammatory conditions, infection, tissue injury and malignancy, all of which have ↑levels of inflammatory cytokines and of the acute phase protein, hepcidin. The anaemia develops in part due to inadequate iron delivery to the marrow, in spite of normal or increased iron stores.
• Cytokines:
- Inhibit release of erythropoietin (EPO) from the kidney.
- Suppress the response of the marrow to EPO.
- Promote haemolysis of senescent red cells.
- Promote release of hepcidin from the liver (acute phase response).
∴ ↓ red cell production in marrow + ↓ red cell survival + ↑ hepcidin.
• Hepcidin:
- Inhibits iron absorption from the intestine and inhibits iron transfer from marrow particles to developing erythrocytes and release of iron from other storage sites. These effects cause a fall in serum iron and poor haemoglobinisation of red cells.
∴ ↓ iron absorption + ↓ release of iron from stores.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Describe the morphology of anaemia of chronic disease.

A
  • Looks like iron deficiency but is mild.
  • Mild microcytic, hypochromic RBCs (often cells are normocytic and normochromic).
  • Decreased RBC and reticulocytes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Outline the investigations for anaemia of chronic disease.

A
• FBC
• Iron studies:
- Ferritin levels are normal/high.
- TIBC low.
- Transferrin low.
26
Q

Describe the management of anaemia of chronic disease.

A
  • Erythropoietin.

* Resolution of inflammation (address underlying cause).

27
Q

Outline aplastic anaemia.

A
  • Due to bone marrow failure → blast cells do not divide.
  • The whole marrow appears empty with very few cells (non-functioning blasts).
  • Most common causes are drugs, immune, viral infections - can suppress bone marrow (e.g. Hep B).
  • Affects all cell lines, stem cells not dividing.
  • Normocytic, normochromic RBCs with pancytopenia (decreased WBCs, decreased platelets).
  • Clinical features - anaemia (↓ RBC), infections (↓ WBC), bleeding (↓ platelets).
  • Neoplasia of stem cells → can give rise to myelodysplastic syndrome and leukaemia.

• Normal Bone Marrow Histology:

  • Fat cells occupy approx 50% of space.
  • Myeloid cells stain blue & have a folded, lobulated nucleus.
  • Erythroid cells stain pink and are round.
28
Q

Outline haemolytic anaemia:
• Aetiology
• Pathogenesis
• Clinical features

A
  • Anaemia due to increased breakdown/destruction of RBCs ∴ RBC have a reduced life span (< 120 days).
  • Increased bilirubin → jaundice (unconjugated).
  • Increased RBC production - BM hyperplasia and increased reticulocytes (bone marrow may increase its output of red blood cells by releasing reticulocytes prematurely).
  • Aetiology: can be either inherited or acquired.
  • Pathogenesis: destruction of RBC.
  • Clinical features:
  • Acute: present with pallor, jaundice (normal urine). Immediate pallor then gradual development of jaundice. If this continues for months/years → chronic.
  • Chronic: splenomegaly, pigment gall stones (may also be liver enlargement and BM hyperplasia).

• Intravascular and extravascular haemolysis*
- 2 types of haemolytic anaemia: intravascular (RBCs broken down within blood vessel - more dangerous) and extravascular (RBCs broken down outside blood vessel - in spleen or liver).

29
Q

Describe the mechanism of RBC breakdown normally and in haemolytic anaemia.

A

Normal:
• Broken down RBC releases globin, iron and porphyrin ring:
- Globin and iron recycled.
- Porphyrin ring becomes unconjugated bilirubin (insoluble and toxic) in the macrophages (both spleen and liver) → transported to liver → conjugated (made soluble and non-toxic by liver) → conjugated bilirubin safely excreted in urine (normal colour).

Haemolytic disease:
• More RBCs broken down then what liver can handle - excess unconjugated bilirubin accumulates in body → jaundice.

30
Q

Explain intravascular haemolysis:
• Aetiology
• Lab diagnosis
• Clinical features

A

• Breakdown of RBC within blood vessel.
• Aetiology:
- Immune (haemolytic especially cold), mechanical damage, enzyme deficiency, transfusion mismatch (wrong blood group - whole transfused blood undergoes haemolysis), drugs, infections e.g. malaria, DIC.

• Lab diagnosis:

  • Absent haptoglobins
  • Haemoglobinemia
  • Haemoglobinuria
  • Haemosiderinuria

• Clinical features: shock, renal failure.

  • Normal - excess (free) Hb forms Hb dimers and initially, the small amount of Hb released is handled by serum globin known as haptoglobin (safely handles Hb) → gets converted to unconjugated bilirubin in the macrophages.
  • Intravascular haemolysis - when loss of Hb is too much within the blood, haptoglobin becomes exhausted. Excess dimers produce haemoglobinemia, haemoglobinuria and haemosiderinuria (all very toxic to kidney) → renal failure.
31
Q

Describe the morphology of haemolytic anaemia.

A
  • Abnormal RBC shapes - spherocytes in WIHA, target forms in thalassemia etc.
  • Polychromatophils - immature RBC - large, bluish, no central pallor - reticulocytes.
  • Nucleated RBC - small nucleus inside reticulocyte.
  • Normocytic, normochromatic RBC.
  • Increased reticulocytes and nucleated RBC precursors.
  • Red blood cell fragments (suggest microangiopathic haemolysis).
  • Spherocytes (small, red, dark cells suggesting autoimmune haemolysis or hereditary spherocytosis).
  • Sickle cells (suggest haemoglobinopathy - sickle-cell disease)
32
Q

Outline the investigations for haemolytic anaemia.

A

• FBC:

  • Hb and RBCs low.
  • MCV high.
  • Reticulocytes high.
  • WBCs and platelets high.
  • Look similar to MBA - only difference is that WBCs and platelets will be high (inflammatory status in the body - in response to cell breakdown, there will be increased WBCs and platelets in body) - how to differentiate between MBA and haemolytic*
  • Also look at reticulocyte count - very high in haemolytic anaemia, mild increase in MBA.
  • Can do a special stain (reticulocyte stain) - Methylene blue stain for cytoplasmic RNA.
33
Q

Outline the aetiology of immune haemolytic anaemia.

A
• Warm (most common):
- Idiopathic 50%.
- Secondary to lymphoid neoplasm, solid tumours, drugs etc.
• Cold:
- Infections (viral).
- Lymphoma.
34
Q

Describe the pathogenesis of immune haemolytic anaemia.

A

RBC antibody - 2 types:
• Warm - IgG
- Coated RBC lysis in spleen (predominantly extravascular).
- IgG binds to RBC & cause destruction mainly in spleen.
- May or may not bind complement.

• Cold - IgM

  • RBC clumping and complement fixation, lysis in blood vessel and liver (predominantly intravascular).
  • IgM antibody attaches to RBC in peripheral circulation & binds.
  • Complement → RBC destruction in reticuloendothelial system
  • RBC clumping and complement fixation occurs in the blood vessel → directly puncture RBCs membrane to cause rupture within the blood vessel or release RBCs with the activated complement C3b coated on it → lysis by liver macrophages. Intravascular more common.
  • Caused by antibody binding to RBC surface antigens.
  • Antibody binding results in red blood cell opsonisation & phagocytosis in spleen or complement fixation → intravascular haemolysis.
35
Q

Identify the clinical features of immune haemolytic anaemia.

A
  • Acute: anaemia (pallor), jaundice. Cyanosis of extremities (cold).
  • Chronic: splenomegaly.
36
Q

Describe the morphology of immune haemolytic anaemia.

A

• Warm:
- Microspherocytes (dark RBC with no central pallor).
- Nucleated RBC.
- Polychromasia (large pale RBC with no central pallor).
- Erythroid hyperplasia.
- Evidence of haemolysis.
• Cold:
- RBC clumps on blood film (prepared at room temp).
- Reticulocytes.

37
Q

Outline the investigations of immune haemolytic anaemia.

A

• Coombs Test +ve

38
Q

Describe the management of immune haemolytic anaemia.

A
  • Warm: immunosuppression, treat underlying cause.

* Cold: maintain warmth of extremities, corticosteroids, blood transfusion.

39
Q

How are spherocytes formed in warm but not cold?

A
  • IgG antibodies coat the surface of RBC. Such RBCs are abnormal - recognised by macrophages in spleen.
  • Macrophages recognise and pinch off antibody stuck portion of the membrane. During passage through the spleen, RBCs lose portion of membrane attached to Ab.
  • Gradual loss of membrane results in small, round, stiff RBC (spherocytes) - to stiff to go through capillaries → break down in capillary (intravascular) or in spleen by macrophages (majority).
40
Q

Explain the Coombs test.

A

• Coombs test is diagnosis for immune haemolytic anaemia.
• Direct:
- The test measures RBCs coated by the IgG Ab → patient RBCs mixed with anti-human globulin Ab → clumping +ve (patient RBCs coated by Abs).
- Identifies antibodies attached to RBCs and which are causing haemolysis - added antibody causes visible agglutination.
• Indirect:
- Abs may be present in the serum but not directly coating RBCs (indirect) - take patient’s serum and incubate with normal RBCs (reagent RBCs) - if you see binding, means the serum of the patient has antibodies.
- Identifies circulating antibodies to RBCs (not attached to RBCs).
• Usually in lab - do direct Coombs → if -ve → do indirect.

41
Q

Outline the aetiology of Microangiopathic Haemolytic Anaemia (MAHA).

A

Due to mechanical damage:
• DIC, TTP, HUS.
- Most common aetiology is infections (DIC) where fibrin threads formed within the blood vessels literally slice RBCs into pieces. Broken RBCs are known as schistocytes (diagnostic feature*).
- Can be seen in many conditions - DIC, TTP, HUS or formation of thrombi within blood vessels.
• Valve disease/artificial (prosthetic) valves.
- RBCs can be damaged by abnormal valves; stenosis - projecting off high speed blood flow.
• March Haemoglobinuria.
- People who are walking for long distances, heavy/strenuous exercise - compression and damage of RBCs within foot capillaries.

42
Q

Describe the morphology of Microangiopathic Haemolytic Anaemia (MAHA).

A
  • Fragmented RBC - schistocytes.
  • Polychromasia - reticulocytes (in response to increased breakdown of RBCs, there will be increased production of immature RBCs - reticulocytes).
43
Q

Identify the 3 main types of congenital haemolytic anaemia.

A
  • Defective membrane - spherocytic anaemia.
  • Defective haemoglobin - sickle cell anaemia, thalassemia.
  • Deficient enzyme - G6PD deficiency anaemia.
44
Q

Outline the aetiology and pathogenesis of hereditary spherocytosis.

A
  • Aetiology - dominant inheritance (25% of cases recessively inherited), due to defect in structural protein of RBC cell membrane. Commonest type is spectrin deficiency (cytoskeleton).
  • Pathogenesis - defect in structural protein causes RBC to lose membrane and become converted to spherocytes (circular) which are phagocytosed & removed in spleen.
  1. Primary membrane skeletal defect.
  2. ↓ membrane stability.
  3. Membrane loss.
  4. ↓ surface to volume ratio (spherocytosis), ↓ deformability.
  5. Splenic trapping.
  6. Erythrostasis ↓ glucose ↓ pH.
  7. Phagocytosis, extravascular haemolysis.
45
Q

Describe the morphology of hereditary spherocytosis.

A
  • Spherocytes - small dense circular cells with loss central pallor.
  • Increased polychromatic cells - more immature RBCs.
46
Q

Identify the clinical features of hereditary spherocytosis.

A
  1. Chronic haemolytic anaemia (from birth or late).
  2. Plenty of spherocytes (more than in WAHA).
  3. Massive splenomegaly (because so many RBCs being broken down in spleen).
  4. Cholecystitis and cholelithiasis (gallstones due to excess bilirubin.
  5. Aplastic, megaloblastic or haemolytic crisis.
    - Aplastic crisis - bone marrow suddenly goes non-functional.
    - Megaloblastic crisis - megaloblastic attack due to sudden loss of vitamin B12/folate.
    - Haemolytic crisis - sudden exacerbation of haemolysis.
  • Coombs test -ve (not autoimmune).
  • Treatment - removal of spleen.
47
Q

Outline the aetiology and pathogenesis of G6PD deficiency.

A
  • Aetiology - is an X-linked condition causing lack of G6PD enzyme. Commonest enzyme deficiency disorder.
  • Pathogenesis - Normally G6PD protects haemoglobin & RBC membrane from oxidative damage by reducing glutathione. Therefore, ↓G6PD → Red blood cells are unusually susceptible to oxidant damage (free radicles). ‘Oxidative haemolysis’.
  • RBC carrying oxygen → oxidative damage is due to hydrogen peroxide formation. Normally G6PD enzyme coverts H2O2 into water (oxidative damage reduced to water) - protective mechanism.
  • In case of G6PD deficiency, there is excess oxidative damage (burning occurs within RBC) → leads to Heinz bodies (abnormal globins - globins get precipitated), bite and blister cells (water is lost, Hb becomes solid - dry RBC) → results in haemolysis (occurs following oxidative damage) → splenomegaly, gallstones.
48
Q

Describe the morphology of G6PD deficiency.

A

• Increased poikilocytosis (contracted red cells, bite cells and blister cells)
- Bite cells typical of G6PD deficiency.
- Blister cell is when the cell membrane is still seen.
• Oxidised, denatured Hb is seen as RBC inclusions (Heinz bodies).
- Abnormal deposition of global chains (special reticulin stain) - small dots - Heinz bodies.
• RBC have ‘blebs’.

• All these cells - abnormal forms - destroyed in spleen.

49
Q

Identify the clinical features of G6PD deficiency.

A
  1. G6PD deficiency.
  2. Oxidative damage (old TBC).
  3. Heinz bodies (globes).
  4. Bite and blister cells (dry RBC*).
  5. Episodic haemolysis.
  6. Splenomegaly, gallstones.
  • Usually young age but can occur in adults too.
  • Treatment - normally self-limiting.
50
Q

Describe the change in composition of haemoglobin following birth

A
  • During embryonic life, variations of unknown Hb for us.
  • At time of birth - only alpha and gamma chains predominant (HbF or foetal Hb) - has high oxygen affinity - can absorb more oxygen from the plasma. However, HbF cannot release oxygen easily so after birth need highly efficient Hb (alpha and beta chains) - HbA or adult Hb.
  • HbF = 2 alpha chains and 2 gamma chains.
  • HbA = 2 alpha chains and 2 beta chains.
  • At birth - HbF 75%, HbA 25%.
  • In first 6 months - all the RBCs carrying HbF die and are replaced by adult RBCs (HbA 97%).
  • Physiologic anaemia - phase where transition is occurring - babies <6 months will have severe anaemia physiologically.
51
Q

Differentiate between the 2 types of haemoglobin disorders.

A
  • Qualitative (abnormal function) - abnormal chains of the globin - haemoglobinopathy e.g. sickle cell anaemia.
  • Quantitative (abnormal amount) - globin chains are normal but there is decreased production of any one of the globin chains (defect in gene itself - globin chains not produced sufficiently) - Thalassemia.
52
Q

Outline the aetiology and pathogenesis of thalassemia.

A

• Quantitative Hb defect - globin deficiency.
• Aetiology/Pathogenesis:
- Defective globin chain synthesis.
- Mutations in α or β globin genes result in ↓ haemoglobin synthesis (genetic defect resulting in a decreased production of one of the chains).
- Accumulation of the unaffected chain results in damage to the developing and mature erythrocytes → RBC destruction.

  1. Decreased normal Hb - microcytic, hypochromic anaemia.
  2. Increased destruction - haemolytic anaemia.
  3. Increased marrow hyperplasia - bossing of head, protrusion of jaw/maxilla. Severe anaemia with haemolysis.
  4. Increased iron - haemochromatosis - increased iron deposition - early damage to heart, liver, lungs due to excess iron.
53
Q

Describe the morphology of thalassemia.

A
  • Microcytic, hypochromic.
  • Target cells present in β-thalassemia.
  • Howell-Jolly bodies present in β-thalassemia.
  • Spherocytes.

Excess α or β chains aggregate to form abnormal tetramers (Heinz bodies, basophilic stippling etc.)
E.g. α thalassemia → decreased α chain → decreased Hb → excess β forms abnormal tetramers (Heinz bodies, basophilic stippling etc.)

54
Q

Identify the clinical features of thalassemia.

A
  • Minor/trait: normal/mild anaemia. Microcytic, hypochromic, target cells.
  • Major: severe haemolytic anaemia (transfusion dependent).
  • Clinical features are a wide spectrum depending on type of chain not produced properly, including severe anaemia, splenomegaly, heart failure, premature death, etc.
  • Treatment: bone marrow transplant.
55
Q

Outline the aetiology and pathogenesis of sickle cell anaemia.

A

• Qualitative Hb defect - abnormal globin.
• Most common congenital haemolytic anaemia.
• Aetiology/Pathogenesis:
- Homozygous Inheritance
- Mutation in β-globin of Hb (HbS) causes formation of long polymers (crystallised Hb due to deoxygenation) that distort RBC (become sickle shaped) which are then destroyed.
- Abnormal RBC block blood vessels & cause acute pain/infarction.

  • Mutation at position 6 of β chain which transforms glutamic acid to valine → results in HbA and HbS.
  • Genetically transmitted mutation disorder where the produced Hb becomes like a crystal when it is deoxygenated.
  • Sickled RBCs become sticky and stiff → leads to blockage of capillaries (more in spleen as the splenic sinusoids are very tortuous plus plenty of macrophages).
  • The sickle cells cause obstruction/infarction of spleen and these RBCs are broken down by macrophages.
  • The sickle cells also block lung capillaries → infarctions of lungs (pulmonary embolism). Pulmonary infarction known as acute chest syndrome.
  • Bone marrow also effected.
  • Every part of body can undergo focal small microscopic necrosis infarction known as crisis (painful necrosis - pain somewhere suddenly - bones, skin, internal organs ‘sickle cell crisis’).
56
Q

Describe the morphology of sickle cell anaemia.

A
  • Presence of sickle cells (darker as Hb is reason for the sickle shape)
  • Anisocytosis.
  • Poikilocytosis.
  • Target cells.

• As there is increased breakdown of cells - there is inflammation in the body → more neutrophils, more platelets.

57
Q

Identify the clinical features of sickle cell anaemia.

A
Clinical features:
• Anaemia
• Jaundice
• Gallstones
• Leg ulcers
• Auto-splenectomy
• Crisis*
• Retinopathy
• Acute respiratory distress
• Cor pulmonale
• Haematuria
• Polyuria
• Aseptic bone necrosis
• Osteomyelitis
• Ischaemic stroke
• Cholecystitis
• Haemosiderosis

Treatment:
• Exchange transfusion of RBC during severe exacerbations.
• Prophylaxis of folic acid & penicillin (to prevent pneumococcal infection).
• NB: Use of vasoconstrictor drugs is contraindicated.

58
Q

Identify the different types of polycythemia.

A

• Relative or spurious erythrocytosis.
• Absolute erythrocytosis (true polycythemia - conditions where RBCs increase):
- Secondary - tissue hypoxia.
- Primary - polycythemia rubra vera.

59
Q

Outline relative or spurious erythrocytosis.

A

• Dehydration: diarrhoea, vomiting, diuretics, excess alcohol etc. (all these conditions cause generalised decreased fluid in blood - ↓plasma volume → Hb artificially high).

60
Q

Outline absolute erythrocytosis.

A

• Secondary: tissue hypoxia - smoking (CO), high altitude, lung disease (e.g. COPD), cardiac shunts (right to left e.g. cyanotic congenital heart disease), high O2 affinity Hb (foetal Hb), high erythropoietin - paraneoplastic syndromes, androgen therapy.
- Secondary causes most common clinically.

• Primary: polycythemia rubra vera - myeloproliferative disorder - neoplastic proliferation of erythroid cells in bone marrow - old age, present with hepatosplenomegaly and flushed skin.
- Idiopathic.

• The JAK test (Janus kinase test) is a molecular biology test which differentiates primary from secondary polycythemia. It identifies the chromosomal abnormality which is present in all cases of polycythemia vera.